- Home
- Services
- czech republic
- lead analysis
Show results for
Refine by
Lead Analysis Services Available In Czech Republic
5 services found
by:Synthego based inMenlo Park,, CALIFORNIA (USA)
For CRISPR-based therapies, understanding the potential and actual off-target edits associated with your CRISPR drug components is critical to their safety and efficacy. Synthego has partnered with SeQure Dx, a leading off-target editing analysis company, to bring you best-in-class OTE analysis for your RUO-to-GMP gRNAs. Whether you are deciding ...
Manufactured by:PharmaBlock Sciences (Nanjing), Inc. based inNanjing, CHINA
Virtual screening is a computational approach used to search libraries of small molecules in order to identify hit and even lead compounds. Because of its significantly lower cost, shorter turnaround time, and particularly access to libraries with substantial larger size compared to the traditional High Throughput Screening (HTS), it has quickly become one of the major drug discovery technologies ...
Manufactured by:Capitainer AB based inSolna, SWEDEN
Capitainer offers innovative lead testing solutions tailored for laboratories aiming to provide effective lead exposure analysis. Their flagship product, the Capitainer®B10, is a state-of-the-art blood collection device known for its precision in testing, making it an ideal choice for labs focusing on lead testing. For labs ...
by:Indivumed GmbH based inHamburg, GERMANY
IndivuType uses our highest quality biospecimens and clinical data, combined with leading-edge analytical methods, to offer a unique multi-omics database. Thus, providing new insights into the biology of cancer and enabling new discoveries in the postgenomic ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro is an medical imaging CRO with over 210 scientists, 60+ PhD’s and MD’s and 2100+ qualified imaging centers across the globe. We possess scientific and regulatory expertise, project management scale and operational excellence to manage all the clinical trial imaging components of your Phase I-IV clinical trials across the therapeutic spectrum and spanning imaging ...